INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 289
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Regenics

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'A more intelligent approach to your health.' Membership framing across weight loss, biomarker testing and testosterone optimization, each 'Starting at $249/month'.

Audienceread

US consumers seeking peptide, weight-loss and hormone care via membership telehealth.

Pricing & termsverified

Weight loss and testosterone optimization each advertised 'Starting at $249/month'. Other program prices not published on reviewed pages.

Clinical relationshipspartial

Membership telehealth: strategic weight-loss programs, comprehensive biomarker testing, testosterone optimization; clinician-guided.

Pharmacy & fulfillmentpartial

Pharmacy partners not named on reviewed pages.

Advertising snapshotpartial

Google: Count header displayed '0 ads' while 1 card from verified advertiser 'Regenics LLC' rendered (20 Oct 2026; known display inconsistency, treated as dated lower bound). Meta: US keyword lookup for 'regenics.com' displayed ~24 results on 20 Oct 2026; keyword results can include affiliates. LinkedIn: No attributable LinkedIn ads; 288 fuzzy accountOwner matches were unrelated advertisers.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.